Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge

News | Stroke

Philips and World Stroke Organization Partner to Improve Access to High-quality Stroke Care

October 12, 2023 — Royal Philips, a global leader in health technology, and the World Stroke Organization (WSO), the ...

October 12, 2023

Novel platform for structural heart interventions now in human use, with ability to improve patient recovery and reduce anesthesia and hospital stays

News | Structural Heart

UltraNav System Enables Safer and More Cost-Effective Transseptal Procedures by Aligning Catheter and Ultrasound

October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which ...

October 12, 2023

News | Cardiovascular Clinical Studies

BioCardia Announces Completion of Enrollment in Phase III CardiAMP HF Trial and Plans for CardiAMP HF Trial II

October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

October 12, 2023

Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications almost a year later

News | Coronavirus (COVID-19)

Unvaccinated Covid-19 Survivors Face Higher Risk of Heart Complications, Singapore Study Finds

October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...

October 11, 2023

Combination of Tenaya’s HDAC6 inhibitors with Empagliflozin Shows Additive Benefits in Preclinical HFpEF Model and Highlights Differentiated Mechanism of Action

News | Heart Failure

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...

October 11, 2023

Technology-powered collaboration aims to deliver AI-enabled devices and digital solutions at the enterprise level to increase clinical and operational efficiencies, drive workflow enhancements and improve patient outcomes

News | Cardiovascular Business

GE HealthCare and University Hospitals Enter 10-Year Strategic Collaboration to Contemporize Its Imaging Fleet and Implement Enterprise Digital Solutions to Help Improve Patient Care and Optimize Processes

October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...

October 11, 2023

Feature | Cardiovascular Clinical Studies | Christine Book

“One on One” with Christine Seidman, MD, FACC, on Hypertrophic Cardiomyopathy

October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy ...

October 10, 2023

REBALANCE-HF early feasibility trial met objective of identifying responder group with demonstrated benefits in heart function, hemodynamics, and physical activity at 6 months

News

Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

October 10, 2023

The study marks a new standard for inclusive medicine with recruitment for target demographics reaching over 3x the national average

News | Cardiovascular Clinical Studies

Hawthorne Effect Announces Monumental Diversity in Patient Recruitment Data for Valvular Heart Disease Study

October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interim recruitment results for the ...

October 10, 2023

News | TCT

Cardiovascular Research Foundation Announces TCT 2023 Award Winners

October 10, 2023 — The recipients of two prestigious awards — the Career Achievement Award and the TCT Geoffrey O ...

October 10, 2023

Feature | Stroke

Philips in Partnership with the World Stroke Organization: Putting Stroke on the Global Agenda

The global incidence of non-communicable diseases (NCDs) is currently around 40 million cases a year. Of that total ...

October 10, 2023

The program is recommended by the Centers for Medicare and Medicaid services for patients who undergo heart valve repair or replacement

News | Heart Failure

TAVR: Less Than One-third of Patients Enter Cardiac Rehab After Heart Procedure

October 9, 2023 — The vast majority of people who have a minimally invasive heart valve replacement procedure do not ...

October 09, 2023

Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key disease-mediating pathways. RJB-0402 demonstrated efficacy in a mouse model of arrhythmogenic cardiomyopathy (ACM)

News | Sudden Cardiac Arrest

Rejuvenate Bio Announces Preclinical Data for Gene Therapy Candidate RJB-0402 for the Treatment of Arrhythmogenic Cardiomyopathy

October 9, 2023 — Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key ...

October 09, 2023

Endotronix announced FDA approval for the PROACTIVE-HF 2 IDE trial with the Cordella Sensor to expand market access and shared positive results from a substudy of their pivotal PROACTIVE-HF clinical trial. The company plans to share full results from the PROACTIVE-HF trial next year.

News | Cardiovascular Clinical Studies

Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial

October 9, 2023 — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment ...

October 09, 2023

News | Pediatric Cardiology

Rady Children’s Appoints Adel Younoszai, MD, as Rady Children’s Hospital Co-Director of the Heart Institute, and Division Chief of Cardiology, Department of Pediatrics, UC San Diego

October 6, 2023 — Rady Children’s Hospital-San Diego, the largest children’s hospital on the West Coast and one of the ...

October 06, 2023